BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34525267)

  • 1. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
    Gu H; Deng W; Zheng Z; Wu K; Sun F
    Immun Inflamm Dis; 2021 Dec; 9(4):1686-1695. PubMed ID: 34525267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR4
    Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
    Immunobiology; 2022 May; 227(3):152210. PubMed ID: 35358941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD13
    Zhang J; Xu X; Shi M; Chen Y; Yu D; Zhao C; Gu Y; Yang B; Guo S; Ding G; Jin G; Wu CL; Zhu M
    Oncoimmunology; 2017; 6(2):e1258504. PubMed ID: 28344866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
    Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
    Front Immunol; 2022; 13():993444. PubMed ID: 36685592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
    Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
    Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.
    Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X
    Front Immunol; 2020; 11():577253. PubMed ID: 33584644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
    Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
    Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
    Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
    Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma.
    Holokai L; Chakrabarti J; Lundy J; Croagh D; Adhikary P; Richards SS; Woodson C; Steele N; Kuester R; Scott A; Khreiss M; Frankel T; Merchant J; Jenkins BJ; Wang J; Shroff RT; Ahmad SA; Zavros Y
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348809
    [No Abstract]   [Full Text] [Related]  

  • 13. CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function.
    Chun E; Lavoie S; Michaud M; Gallini CA; Kim J; Soucy G; Odze R; Glickman JN; Garrett WS
    Cell Rep; 2015 Jul; 12(2):244-57. PubMed ID: 26146082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.
    Zhao Z; Qin J; Qian Y; Huang C; Liu X; Wang N; Li L; Chao Y; Tan B; Zhang N; Qian M; Li D; Liu M; Du B
    J Hematol Oncol; 2024 Feb; 17(1):9. PubMed ID: 38402237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
    Xiang H; Ramil CP; Hai J; Zhang C; Wang H; Watkins AA; Afshar R; Georgiev P; Sze MA; Song XS; Curran PJ; Cheng M; Miller JR; Sun D; Loboda A; Jia Y; Moy LY; Chi A; Brandish PE
    Cancer Immunol Res; 2020 Apr; 8(4):436-450. PubMed ID: 32075803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
    Okabe J; Kodama T; Sato Y; Shigeno S; Matsumae T; Daiku K; Sato K; Yoshioka T; Shigekawa M; Higashiguchi M; Kobayashi S; Hikita H; Tatsumi T; Okamoto T; Satoh T; Eguchi H; Akira S; Takehara T
    J Exp Clin Cancer Res; 2023 Oct; 42(1):262. PubMed ID: 37814340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients.
    Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
    Scand J Immunol; 2021 Dec; 94(6):e13107. PubMed ID: 38192074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.